Fresh Insights into UK Life Science Company Start-Ups
Posted on 24. Sep, 2010 by editor in Business News
A new report, UK Life Science Start-Up Report 2010, has reported that there are vast, untapped opportunities to start up and develop life science companies across the UK.
The report, by Mobius Life Sciences Fund and BioCity Nottingham helps to identify these opportunities and calls for any public investment to be better targeted at four UK ‘hot spots’. It also highlights opportunities for investors in the sector across the UK.
The report is the first comprehensive study of early stage life science firms and specifically looks at the levels of university spin-out activity, the geographic spread of early stage and subsequent investments, the role of bio-business incubators and the likely opportunities presented by the restructuring of the global pharmaceutical industry.
Author of the report and CEO of BioCity, Dr Glenn Crocker, joined a gathering of industry experts, government officials and the press at The British Library, to present the findings of the report. He said: “There is no getting away from the fact that this country needs to invest if it wants a successful bioscience industry, but historically the jam has been spread too thinly. It’s not simply about how many start-ups are created; it’s about how well university research is turned into business opportunities and the start in life that the companies achieve.”
Lucy P. Marcus, who chairs the Mobius Life Science Fund and is a BioCity board member, added: “Investment in life sciences is essential and in times of ever decreasing funding, knowing where investment can be the most effective and have the greatest impact is essential. This report will help bring some clarity to investment choices, both with public and private money.”
